CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 59 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,931 | -49.2% | 48,583 | -20.4% | 0.00% | – |
| Q2 2023 | $139,690 | +1143.6% | 61,000 | +361.6% | 0.00% | – |
| Q4 2022 | $11,233 | +12.3% | 13,215 | +7.4% | 0.00% | – |
| Q3 2022 | $10,000 | -76.7% | 12,300 | -71.5% | 0.00% | – |
| Q2 2022 | $43,000 | -94.6% | 43,100 | -91.1% | 0.00% | – |
| Q1 2022 | $793,000 | +90.2% | 483,645 | +179.9% | 0.00% | – |
| Q4 2021 | $417,000 | -84.3% | 172,780 | -68.6% | 0.00% | – |
| Q3 2021 | $2,659,000 | +1299.5% | 549,500 | +668.8% | 0.00% | – |
| Q2 2021 | $190,000 | -56.5% | 71,478 | -49.6% | 0.00% | – |
| Q1 2021 | $437,000 | +756.9% | 141,871 | +885.2% | 0.00% | – |
| Q4 2020 | $51,000 | +21.4% | 14,400 | -7.2% | 0.00% | – |
| Q2 2020 | $42,000 | -55.8% | 15,519 | -65.7% | 0.00% | – |
| Q1 2020 | $95,000 | +53.2% | 45,262 | +167.8% | 0.00% | – |
| Q4 2018 | $62,000 | -65.9% | 16,904 | -20.5% | 0.00% | – |
| Q3 2018 | $182,000 | – | 21,264 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $8,746,000 | 1.82% |
| Telemetry Investments, L.L.C. | 263,975 | $705,000 | 0.97% |
| CHI Advisors LLC | 719,132 | $1,920,000 | 0.45% |
| BVF INC/IL | 3,678,626 | $9,822,000 | 0.37% |
| EcoR1 Capital, LLC | 3,579,377 | $9,557,000 | 0.36% |
| Orbimed Advisors | 8,053,298 | $21,502,000 | 0.22% |
| Stonepine Capital Management, LLC | 46,886 | $125,000 | 0.06% |
| Ikarian Capital, LLC | 100,000 | $267,000 | 0.02% |
| ALGERT GLOBAL LLC | 19,737 | $53,000 | 0.02% |
| Windsor Creek Advisors, LLC | 14,786 | $39,000 | 0.01% |